Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events.
Dario CalderoneSalvatore IngalaMaria Sara MauroDominick J AngiolilloDavide CapodannoPublished in: Expert review of cardiovascular therapy (2021)
inhibitor is used, hence reducing the bleeding risk with no rebound in thrombotic events.